Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Emergence Delirium × Methylene Blue × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Stomach Neoplasms 2 Warts 1 Uterine Cervical Neoplasms 1 Solitary Pulmonary Nodule 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Pulmonary Nodules 1 Melanoma 1 Lymphedema 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Emergence Delirium 1 Disease 1 Colorectal Neoplasms 1

Interventions

Saline Solution 3 Propofol 3 Dexmedetomidine 3 remimazolam 2 Sugammadex 1 Sufentanil 1 Spectroscopy, Near-Infrared 1 Sodium Chloride 1 Ropivacaine 1 Pyridostigmine Bromide 1 Neuroleptanalgesia 1 Nalbuphine 1 Minocycline 1 Midazolam 1 Methylene Blue 1 Ketamine 1 Injections 1 Ibuprofen 1 Duloxetine Hydrochloride 1 Blood Specimen Collection 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04529265 2025-05-14

Methylene Blue and Postoperative Neurocognitive Disorders

Fudan University

Phase NA Completed

Emergence Delirium

Data powered by HemOnc (CC BY 4.0) Colophon ⚡